Skip to main content
SpringerLink
Log in

Barnidipine

A Viewpoint by Luis M Ruilope

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brown MJ, Palmer CR, Casteigne A, et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 536: 366–72

    Article  Google Scholar 

  2. Blood pressure Lowering Treatment Trialist Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 355: 1955–64

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hypertension Unit, Universidad Complutense, Madrid, Spain

    Luis M. Ruilope

Authors
  1. Luis M. Ruilope
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruilope, L.M. Barnidipine. Drugs 61, 997 (2001). https://doi.org/10.2165/00003495-200161070-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200161070-00008

Search

Navigation